Valuation AUXESIS 03/2024
Valuation AUXESIS 03/2024 Fintegrity AB – Scenario One Pager valuation of the shares in AUXESIS PHARMA HOLDING AB (publ) prior to the launch of the
March 1, 2024
No Comments
Valuation AUXESIS 03/2024 Fintegrity AB – Scenario One Pager valuation of the shares in AUXESIS PHARMA HOLDING AB (publ) prior to the launch of the
NEW SME STATUS GRANTED BY EMA Auxesis Pharma Holding AB has been granted Small and Medium-sized Enterprise (SME) status as of January 23, 2024, by
ÖFK sponsor one step closer to factory in Ostersund. 15 december 2023 While manufacturing is still pending, shares worth several million kronor were donated to
The patent application is now officially registered! We are thrilled to announce that AUXESIS PHARMA HOLDING AB (publ) has successfully submitted the application for its
Production site AUXESIS PHARMA HOLDING AB (publ) continues its “journey” by visiting the Business Office in Östersund Municipality on Friday 2023-10-27. In addition, Region Jämtland/Härjedalen
AUXESIS PHARMA HOLDING AB (publ) is now a settlement company and started with Euroclear as the securities institution. This is the last phase (according to
Ostersund AUXESIS PHARMA HOLDING AB (publ) is in the establishment phase of pharmaceutical manufacturing in Östersund, Sweden. In September 2023 the company will submit an
Protocol from The AUXESIS PHARMA HOLDING AB (publ) Annual General Meeting 2023 is now available for download in the Investor Hub.
AUXESIS PHARMA HOLDING (publ) Annual report /Årsredovisning and associated documents regarding the Annual Meeting is now available for download in the Investor Hub for investors.
The shareholders of AUXESIS PHARMA HOLDING AB (publ) with organization number 559195-6486 are hereby invited to the annual general meeting on June 16, 2023 at
+46 (0)8-771 43 00
Copyright All rights reserved AUXESIS PHARMA HOLDING AB (publ) 2023